Trial intelligence / Profile preview

Celecoxib for Postoperative Pain in Laparoscopic Gynecologic Surgery

NCT03391570Unknown

Sponsor
Seoul National University Hospital
Start
Oct 2017
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of celecoxib oral solution in postoperative pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change of biomarkers expression (COX-2, prostanoids). Status: unknown.

02

Drugs

celecoxib oral solution
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03391570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03391570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call